Prospectively collected lifestyle and health information as risk factors for white matter hyperintensity volume in stroke patients
- 152 Downloads
Most studies of white matter hyperintensity volume (WMHV) in stroke patients lack reliable information on antecedent exposure to vascular risk factors. By leveraging prospective cohort data, we explored associations between lifestyle and health factors assessed 1 year prior to stroke and WMHV in individuals who experienced an ischemic stroke. This analysis was nested within two large prospective studies of initially healthy individuals. Information on lifestyle factors and health conditions was collected prior to the stroke event through annual or biannual questionnaires. For individuals who experienced their first confirmed ischemic stroke and had available magnetic resonance imaging, we measured WMHV using a validated semiautomated method. Linear regression was used to explore associations between lifestyle factors and health conditions and log-transformed WMHV. We measured WMHV in 345 participants with a first ischemic stroke event (mean age = 74.4 years; 24.9% male). After multivariate adjustment, history of diabetes was associated with decreased WMHV (p value = 0.06) while history of transient ischemic attack (p value = 0.09) and hypertension (p value = 0.07) were associated with increased WMHV. Most lifestyle factors and health conditions measured 1 year prior to stroke were not associated with WMHV measured at the time of ischemic stroke. Future studies could examine whether long term exposure to these factors impacts diffuse microvascular ischemic brain injury among stroke patients.
KeywordsRisk factors White matter hyperintensities Stroke
This work was supported by the National Institutes of Health (CA047988, HL043851, HL080467, HL099355, CA182913, U01 CA138962, R01 CA138962 and HL128791).
Compliance with ethical standards
Conflict of interest
The authors declare that they have no conflict of interest.
- 1.Henon H, Vroylandt P, Durieu I, Pasquier F, Leys D. Leukoaraiosis more than dementia is a predictor of stroke recurrence. Stroke. 2003;34(12):2935–40. https://doi.org/10.1161/01.STR.0000103747.58719.59.CrossRefPubMedGoogle Scholar
- 5.Jeerakathil T, Wolf PA, Beiser A, et al. Stroke risk profile predicts white matter hyperintensity volume: the Framingham Study. Stroke. 2004;35(8):1857–61. https://doi.org/10.1161/01.STR.0000135226.53499.85.CrossRefPubMedGoogle Scholar
- 8.Williamson W, Lewandowski AJ, Forkert ND, et al. Association of Cardiovascular Risk Factors with MRI indices of cerebrovascular structure and function and white matter hyperintensities in young adults. JAMA. 2018;320(7):665–73. https://doi.org/10.1001/jama.2018.11498.CrossRefPubMedPubMedCentralGoogle Scholar
- 9.Cloonan L, Fitzpatrick KM, Kanakis AS, Furie KL, Rosand J, Rost NS. Metabolic determinants of white matter hyperintensity burden in patients with ischemic stroke. Atherosclerosis. 2015;240(1):149–53. https://doi.org/10.1016/j.atherosclerosis.2015.02.052.CrossRefPubMedPubMedCentralGoogle Scholar
- 11.Zhang CR, Cloonan L, Fitzpatrick KM, et al. Determinants of white matter hyperintensity burden differ at the extremes of ages of ischemic stroke onset. J Stroke Cerebrovasc Dis. 2015;24(3):649–54. https://doi.org/10.1016/j.jstrokecerebrovasdis.2014.10.016.CrossRefPubMedGoogle Scholar
- 12.Manson JE, Bassuk SS, Lee IM, et al. The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease. Contemp Clin Trials. 2012;33(1):159–71. https://doi.org/10.1016/j.cct.2011.09.009.CrossRefPubMedGoogle Scholar
- 16.Irizarry MC, Gurol ME, Raju S, et al. Association of homocysteine with plasma amyloid beta protein in aging and neurodegenerative disease. Neurology. 2005;65(9):1402–8. https://doi.org/10.1212/01.wnl.0000183063.99107.5c.CrossRefPubMedGoogle Scholar
- 18.Rost NS, Rahman R, Sonni S, et al. Determinants of white matter hyperintensity volume in patients with acute ischemic stroke. J Stroke Cerebrovasc Dis. 2010;19(3):230–5. https://doi.org/10.1016/j.jstrokecerebrovasdis.2009.05.007.CrossRefPubMedGoogle Scholar
- 19.Rost NS, Sadaghiani S, Biffi A, et al. Setting a gold standard for quantification of leukoaraiosis burden in patients with ischemic stroke: the Atherosclerosis Risk in Communities Study. J Neurosci Methods. 2014;221:196–201. https://doi.org/10.1016/j.jneumeth.2013.10.009.CrossRefPubMedPubMedCentralGoogle Scholar
- 20.Gurol ME, Irizarry MC, Smith EE, et al. Plasma beta-amyloid and white matter lesions in AD, MCI, and cerebral amyloid angiopathy. Neurology. 2006;66(1):23–9. https://doi.org/10.1212/01.wnl.0000191403.95453.6a.CrossRefPubMedGoogle Scholar
- 21.Smith EE, Gurol ME, Eng JA, et al. White matter lesions, cognition, and recurrent hemorrhage in lobar intracerebral hemorrhage. Neurology. 2004;63(9):1606–12. https://doi.org/10.1212/01.wnl.0000142966.22886.20.CrossRefPubMedGoogle Scholar
- 24.Young VG, Halliday GM, Kril JJ. Neuropathologic correlates of white matter hyperintensities. Neurology. 2008;71(11):804–11. https://doi.org/10.1212/01.wnl.0000319691.50117.54.CrossRefPubMedGoogle Scholar
- 25.Eckel RH, Jakicic JM, Ard JD, et al. 2013 AHA/ACC guideline on lifestyle management to reduce cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014;129(25 Suppl 2):S76–99. https://doi.org/10.1161/01.cir.0000437740.48606.d1.CrossRefPubMedGoogle Scholar